Human KIAA1257 siRNA
siRNA to inhibit KIAA1257 expression using RNA interference.
This product is provided as three 5 nmol vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilized siRNA oligo duplexes. Each vial contains slightly different sequences to ensure full knockout of the gene. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
This product is provided as three 5 nmol vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilized siRNA oligo duplexes. Each vial contains slightly different sequences to ensure full knockout of the gene. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx921522-30NMOL |
| Pricing | 30 nmol USD $710.5 |
| Host | Synthetic |
| Tested Applications | RNAi |
| UniProt Primary AC | Q9ULG3 |
| Availability | Shipped within 7-15 working days. |
| Dry Ice | No |
| Note | This product is for research use only. |